Jump to content
RemedySpot.com

CR decreases risk of death, but ...

Rate this topic


Guest guest

Recommended Posts

I chuckled when I finished reading the abstract below. It turns out

that an ad libitum diabetic monkey outlived the CR monkeys, although

the median age of survival was higher for the CR monkeys.

Tony

Bodkin NL, TM, Ortmeyer HK, E, Hansen BC. Mortality

and morbidity in laboratory-maintained Rhesus monkeys and effects of

long-term dietary restriction. J Gerontol A Biol Sci Med Sci. 2003

Mar;58(3):212-9. PMID: 12634286

Mortality and morbidity were examined in 117 laboratory-maintained

rhesus monkeys studied over approximately 25 years (8

dietary-restricted [DR] and 109 ad libitum-fed [AL] monkeys). During

the study, 49 AL monkeys and 3 DR monkeys died. Compared with the DR

monkeys, the AL monkeys had a 2.6-fold increased risk of death.

Hyperinsulinemia led to a 3.7-fold increased risk of death (p <.05);

concordantly, the risk of death decreased by 7%, per unit increase in

insulin sensitivity (M). There was significant organ pathology in the

AL at death. The age at median survival in the AL was approximately 25

years compared with 32 years in the DR. The oldest monkey was a

diabetic female (AL) that lived to be 40 years of age. These results

suggest that dietary restriction leads to an increased average age of

death in primates, associated with the prevention of hyperinsulinemia

and the mitigation of age-related disease.

PMID: 12634286

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...